CDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant Women Parthika Patel4 Jun 2025 3:33 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Vaccines under the Central Drugs Standard Control Organisation (CDSCO) has recommended the conduct...
MSN Labs Gets SEC Nod to Conduct Phase III Trial of Semaglutide Dr. Divya Colin4 Jun 2025 3:10 PM ISTNew Delhi: Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee (SEC) functional...
Revise Phase IV Protocol for Gliclazide-Sitagliptin FDC with Scientific Justification: SEC Tells Eris Dr. Divya Colin4 Jun 2025 3:01 PM ISTNew Delhi: Reviewing the Phase IV clinical trial of Eris Lifesciences' Fixed Dose Combination (FDC) antidiabetic drug Gliclazide plus Sitagliptin, the...
Bayer Prostate Cancer Drug Nubeqa gains third regulatory win from USFDA Ruchika Sharma4 Jun 2025 2:59 PM ISTBerlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for its oral androgen receptor inhibitor (ARi) Nubeqa...
Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK Ruchika Sharma4 Jun 2025 2:29 PM ISTMumbai: Indoco Remedies has announced that its subsidiary company, Indoco Remedies UK Limited, has officially launched Ticagrelor film-coated...
Sanofi Rilzabrutinib gets USFDA orphan drug designation for sickle cell disease Ruchika Sharma4 Jun 2025 1:30 PM ISTParis: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, advanced, oral,...
Sun Pharma discontinues development of skin disease drug after trials failure Ruchika Sharma4 Jun 2025 12:27 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced the discontinuation of two clinical trials evaluating SCD-044, a novel, orally...
USFDA greenlights Gland Pharma BP injection in adults with septic shock Ruchika Sharma4 Jun 2025 11:30 AM ISTHyderabad: Gland Pharma Limited, a generic injectable & ophthalmicfocused pharmaceutical company, has announced that the company has...
Emcure Pharma Anil Kothiyal to resign as President - India Sales & Marketing Ruchika Sharma4 Jun 2025 10:30 AM ISTPune: Emcure Pharmaceuticals Limited has announced the resignation of Anil Kothiyal, President - India Sales & Marketing and Senior...
Full dose escalation data show favorable safety profile of ISB 2001 for Multiple Myeloma: Ichnos Glenmark Innovation Ruchika Sharma3 Jun 2025 5:47 PM ISTNew York: Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics...
Sanofi to acquire Blueprint Medicines for up to USD 9.5 billion Ruchika Sharma3 Jun 2025 3:23 PM ISTParis: Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis...
GSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under USFDA review Ruchika Sharma3 Jun 2025 2:15 PM ISTLondon: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ileal bile...
